Lymphoma & Plasma Cell Disorders
News
Stem Cell Transplant: Physical, Mental Health Burdens Persist
Major Finding: 74% of hematopoietic cell transplant survivors reported having any chronic health condition at least 10 years, compared with 39%of...
News
PBSC Transplants from Unrelated Donors Show No Survival Advantage
Major Finding: Two-year overall survival among 273 patients randomized to receive peripheral-blood stem cells from an unrelated donor was 51% in...
News
HL drug demonstrates activity and toxicity
A novel agent has shown activity in relapsed or refractory Hodgkin lymphoma (HL), but it can cause severe adverse events and even death at a high...
News
NICE Expands Chemotherapy Options with Rituximab
News
Severe Comorbidity Doubles Death Risk in Multiple Myeloma
Major Finding: Median overall survival in patients with severe comorbidity was 15.1 months vs.
News
Novel Therapies Put Multiple Myeloma 'On the Ropes'
News
Transplant Protocol Benefits Elderly With Hematologic Cancers
Major Finding: The 5-year survival was 35% overall and as high as 69% in the lowest-risk patients among those aged 60-75 years whose advanced...
News
PET Scans Key to Less Radiation for Hodgkin's Lymphoma
Major Finding: FDG-PET scans following chemotherapy in patients with advanced-stage Hodgkin’s lymphoma have a negative predictive value of 94%....
News
FDA grants accelerated approval for brentuximab vedotin
The US Food and Drug Administration (FDA) has granted accelerated approval for brentuximab vedotin (Adcetris) to treat patients with Hodgkin...